Biotech

All Articles

Sanofi flunks MS research study, inflicting one more blow to Denali contract

.Sanofi has stopped a phase 2 hardship of Denali Therapeutics-partnered oditrasertib in several scle...

Turnstone lays off 60%, shocks C-suite to stretch out money

.Turnstone Biologics is actually lessening its headcount by 60% and also shaking up its C-suite so a...

Gilead loses hope on $15M MASH wager after mulling preclinical information

.In a year that has observed an authorization and also a boating of readouts for metabolic dysfuncti...

Texas biotech centers cancer cells deal, pins hopes on being overweight

.Alaunos Therapies is axing an agreement with Precigen, surrendering licensing rights to an individu...

Capricor reveals extra records for DMD treatment after starting BLA

.Capricor Therapeutics is taking a success tour for their stage 2 Duchenne muscular dystrophy (DMD) ...

FDA areas Kezar lupus test in grip following 4 person fatalities

.The FDA has positioned Kezar Life Sciences' lupus trial on hold after the biotech flagged four deat...

Phase 3 Scholar Rock test attacks SMA target, delivering stockpile 200%

.A period 3 test of Scholar Rock's vertebral muscular atrophy (SMA) applicant has actually struck it...

CAMP 4 is latest to eye IPO, while Upstream spells out $182M planning

.RNA biotech CAMP4 Therapies has marked out think about a $67 million IPO, along with inflammation-f...

Galecto purchases leukemia medicine, goes down bone cancer cells resource in pivot

.A year after the failing of an idiopathic lung fibrosis prospect sent out Galecto on a seek redempt...

Judo throws down $100M to knock out kidney illness

.Taking the mat is Judo Bio, an up-and-coming biotech equipped along with $one hundred thousand to d...